Published in Women's Health Weekly, June 3rd, 2010
"Gene expression profiles of dasatinib-sensitive and dasatinib-resistant cell lines (n=23) were compared to develop a dasatinib-sensitivity index (modified DS index). A Src pathway activity index...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.